Innovations

Found results: 1005

Note to the businessman

Bigfarma's beastly grin

Is it profitable for pharmaceutical companies to cure patients? An analyst at one of the largest investment banks believes that no.

19.04.2018
Note to the businessman

The stingy rich

With very few exceptions, rich people do not fund rejuvenation research. They age and die, just like the rest of us.

20.03.2018
Biotechnologies - into life

Collected bit by bit

Biochemist was the first in the country to establish a unique production of antibiotics: from the producer strain to ready-made medicines.

20.02.2018
Note to the businessman

Animal Biotechnology – 2018

In the ResearchAndMarkets online store, you can buy an overview of "Animal Biotechnology – technologies, markets and companies".

13.02.2018
Note to the businessman

Personalized Medicine – 2018

The review "Personalized Medicine – Scientific and commercial aspects" has been put on sale.

12.02.2018
Note to the businessman

Bet on chemistry

Jakafi has made Incyte's shares one of the most sought-after on Wall Street, and the company itself has been the subject of endless takeover gossip.

06.02.2018
Note to the businessman

Biotech Stars

Buying small biotech startups means growth for the entire industry, but will pharmaceutical companies invest more actively in such enterprises?

24.01.2018
Note to the businessman

Pharmacy for venture

A venture investor in biotech has two ways to secure his investments: to buy more expensive at late stages or to reduce risks on his own.

16.01.2018
Note to the businessman

Venture Biotech

How biotechnologists learn to "hack microorganisms" and why investors invested almost $1 billion in such startups last year.

15.01.2018
Note to the businessman

Cancer gene therapy and pharmacoeconomics

The introduction of cancer gene therapy will cause serious financial consequences for the health systems of even rich countries.

11.01.2018
Note to the businessman

Novelties of biomedicine

The most interesting and important of the world events in the field of drug development and healthcare for the 2nd half of 2017

26.12.2017
Innovative Russia

Biotechnologies are the future

Roman Kulikov – about the state of technology in Russia, the evolution of the selection of organisms and a mixture of biology, mathematics and IT.

25.12.2017
Note to the businessman

Six million for OncoTartis

The funds will be used to conduct phase I clinical trials of the drug OT-82 for the treatment of resistant forms of acute leukemia.

12.12.2017
Innovative Russia

Why Russians can't change their genes

Alexander Karabelsky from Biocad company – about how we can keep up with the progress in gene therapy and gene editing.

05.12.2017
Innovative Russia

Winners "VIC.Nano 2017"

The authors of the three most interesting works will have the opportunity to visit one of the largest innovation clusters in Europe.

04.12.2017
Note to the businessman

Investing in diabetes treatment

An American startup hoping to cure type one diabetes with an implant with insulin-producing cells has raised $114 million.

30.11.2017